187 related articles for article (PubMed ID: 24416400)
1. A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese.
Qi F; Huang M; Pan Y; Liu Y; Liu J; Wen J; Xie K; Shen H; Ma H; Miao Y; Hu Z
PLoS One; 2014; 9(1):e85394. PubMed ID: 24416400
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma.
Liu Y; Zhang Y; Wen J; Liu L; Zhai X; Liu J; Pan S; Chen J; Shen H; Hu Z
PLoS One; 2012; 7(2):e32230. PubMed ID: 22393390
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.
An J; Liu J; Liu L; Liu Y; Pan Y; Huang M; Qi F; Wen J; Xie K; Ma H; Shen H; Hu Z
PLoS One; 2014; 9(4):e93707. PubMed ID: 24751683
[TBL] [Abstract][Full Text] [Related]
4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant at KIF1B predicts clinical outcome of HBV-related hepatocellular carcinoma in Chinese.
Huang M; Pan Y; Liu J; Qi F; Wen J; Xie K; Ma H; Shen H; Liu Y; Dai J
Cancer Epidemiol; 2014 Oct; 38(5):608-12. PubMed ID: 25153661
[TBL] [Abstract][Full Text] [Related]
6. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
Zhao Q; Li T; Qi J; Liu J; Qin C
PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
[TBL] [Abstract][Full Text] [Related]
7. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.
Wu J; Zhang W; Xu A; Zhang L; Yan T; Li Z; Wu X; Zhu X; Ma J; Li K; Li H; Liu Y
Genet Test Mol Biomarkers; 2013 Aug; 17(8):595-600. PubMed ID: 23790025
[TBL] [Abstract][Full Text] [Related]
8. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
10. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis.
Zhu X; Chen MS; Tian LW; Li DP; Xu PL; Lin MC; Xie D; Kung HF
Int J Cancer; 2009 Sep; 125(6):1352-7. PubMed ID: 19533686
[TBL] [Abstract][Full Text] [Related]
12. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract][Full Text] [Related]
13. A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma.
Xie K; Liu J; Zhu L; Liu Y; Pan Y; Wen J; Ma H; Zhai X; Hu Z
Cancer Epidemiol; 2013 Dec; 37(6):998-1002. PubMed ID: 24103425
[TBL] [Abstract][Full Text] [Related]
14. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
15. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
[TBL] [Abstract][Full Text] [Related]
17. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
18. Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population.
Wang PS; Kuai J; Li H; Wang CG; Shi BJ; Zhong L
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):282-8. PubMed ID: 27298104
[TBL] [Abstract][Full Text] [Related]
19. miR-146a G>C polymorphisms and risk of hepatocellular carcinoma in a Chinese population.
Cong N; Chen H; Bu WZ; Li JP; Liu N; Song JL
Tumour Biol; 2014 Jun; 35(6):5669-73. PubMed ID: 24615520
[TBL] [Abstract][Full Text] [Related]
20. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
